acute myeloid leukamia

Showing 2 posts of 2 posts found.

Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia

March 24, 2020
Manufacturing and Production Cancer, Roche, acute myeloid leukamia

Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …

Astellas’ Xospata becomes US-approved drug for FLT3-mutated acute myeloid leukaemia

November 29, 2018
Sales and Marketing Astellas, FDA, US, Xospata, acute myeloid leukamia

Astellas has revealed that Xospata (gilteritinib) has been awarded FDA approval as a treatment for relapsed or refractory acute myeloid …

Latest content